S&P 500   3,912.22 (+0.79%)
DOW   31,862.62 (+1.03%)
QQQ   322.61 (+0.35%)
AAPL   124.52 (-1.06%)
MSFT   232.95 (-0.14%)
FB   264.72 (-0.43%)
GOOGL   2,071.41 (+0.55%)
AMZN   3,151.29 (-1.35%)
TSLA   731.70 (+4.70%)
NVDA   569.00 (+0.59%)
BABA   249.76 (-1.18%)
CGC   35.58 (+0.76%)
GE   13.22 (+5.00%)
MU   90.97 (+3.11%)
NIO   51.20 (+4.26%)
AMD   85.77 (+1.22%)
T   29.36 (+0.62%)
F   12.04 (+3.61%)
ACB   11.39 (+1.61%)
DIS   199.42 (+1.18%)
BA   227.83 (+7.41%)
NFLX   550.99 (+0.89%)
BAC   36.24 (+2.03%)
S&P 500   3,912.22 (+0.79%)
DOW   31,862.62 (+1.03%)
QQQ   322.61 (+0.35%)
AAPL   124.52 (-1.06%)
MSFT   232.95 (-0.14%)
FB   264.72 (-0.43%)
GOOGL   2,071.41 (+0.55%)
AMZN   3,151.29 (-1.35%)
TSLA   731.70 (+4.70%)
NVDA   569.00 (+0.59%)
BABA   249.76 (-1.18%)
CGC   35.58 (+0.76%)
GE   13.22 (+5.00%)
MU   90.97 (+3.11%)
NIO   51.20 (+4.26%)
AMD   85.77 (+1.22%)
T   29.36 (+0.62%)
F   12.04 (+3.61%)
ACB   11.39 (+1.61%)
DIS   199.42 (+1.18%)
BA   227.83 (+7.41%)
NFLX   550.99 (+0.89%)
BAC   36.24 (+2.03%)
S&P 500   3,912.22 (+0.79%)
DOW   31,862.62 (+1.03%)
QQQ   322.61 (+0.35%)
AAPL   124.52 (-1.06%)
MSFT   232.95 (-0.14%)
FB   264.72 (-0.43%)
GOOGL   2,071.41 (+0.55%)
AMZN   3,151.29 (-1.35%)
TSLA   731.70 (+4.70%)
NVDA   569.00 (+0.59%)
BABA   249.76 (-1.18%)
CGC   35.58 (+0.76%)
GE   13.22 (+5.00%)
MU   90.97 (+3.11%)
NIO   51.20 (+4.26%)
AMD   85.77 (+1.22%)
T   29.36 (+0.62%)
F   12.04 (+3.61%)
ACB   11.39 (+1.61%)
DIS   199.42 (+1.18%)
BA   227.83 (+7.41%)
NFLX   550.99 (+0.89%)
BAC   36.24 (+2.03%)
S&P 500   3,912.22 (+0.79%)
DOW   31,862.62 (+1.03%)
QQQ   322.61 (+0.35%)
AAPL   124.52 (-1.06%)
MSFT   232.95 (-0.14%)
FB   264.72 (-0.43%)
GOOGL   2,071.41 (+0.55%)
AMZN   3,151.29 (-1.35%)
TSLA   731.70 (+4.70%)
NVDA   569.00 (+0.59%)
BABA   249.76 (-1.18%)
CGC   35.58 (+0.76%)
GE   13.22 (+5.00%)
MU   90.97 (+3.11%)
NIO   51.20 (+4.26%)
AMD   85.77 (+1.22%)
T   29.36 (+0.62%)
F   12.04 (+3.61%)
ACB   11.39 (+1.61%)
DIS   199.42 (+1.18%)
BA   227.83 (+7.41%)
NFLX   550.99 (+0.89%)
BAC   36.24 (+2.03%)
Log in
NASDAQ:KRYS

Krystal Biotech Short Interest Ratio and Short Volume

$80.51
+3.95 (+5.16 %)
(As of 02/24/2021 12:50 PM ET)
Add
Compare
Today's Range
$76.93
Now: $80.51
$81.90
50-Day Range
$62.11
MA: $69.60
$76.98
52-Week Range
$33.08
Now: $80.51
$79.00
Volume5,198 shs
Average Volume169,864 shs
Market Capitalization$1.59 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.2

Short Interest

Krystal Biotech (NASDAQ:KRYS) Short Interest Data

Current Short Volume:1,210,000 shares
Previous Short Volume:1,290,000 shares
Change Vs. Previous Month:-6.20%
Dollar Volume Sold Short:$84.83 million
Short Interest Ratio / Days to Cover:7.0
Last Record Date:January, 29 2021
Outstanding Shares:17,320,000 shares
Float Size:14,910,000 shares
Short Percent of Float:8.12%
Today's Trading Volume:5,198 shares
Average Trading Volume:169,864 shares
Today's Volume Vs. Average:-96.94%


Krystal Biotech (NASDAQ:KRYS) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/29/20211,210,000 shares $84.83 million -6.2%8.1%7.3 $70.11
1/15/20211,290,000 shares $91.16 million -5.8%9.6%8.6 $70.67
12/31/20201,340,000 shares $88.83 million -2.2%10.0%9 $66.29
12/15/20201,340,000 shares $83.23 million -2.2%10.0%9 $62.11
11/30/20201,370,000 shares $80.28 million -4.2%10.2%9.8 $58.60
11/15/20201,430,000 shares $78.56 million -7.1%10.7%10.6 $54.94
10/30/20201,540,000 shares $64.50 million -11.0%11.5%12.1 $41.88
10/15/20201,730,000 shares $84.22 million -3.9%13.0%13.6 $48.68
9/30/20201,800,000 shares $91.75 million +8.4%13.5%14.1 $50.97
9/15/20201,660,000 shares $68.71 million +1.8%12.4%11.7 $41.39
8/31/20201,630,000 shares $71.95 million +4.5%12.3%10.8 $44.14
8/14/20201,560,000 shares $75.13 million -3.7%11.7%9.6 $48.16
7/31/20201,620,000 shares $72.09 million +2.5%12.2%8.5 $44.50
7/15/20201,580,000 shares $65.24 million No Change11.9%8.5 $41.29
6/30/20201,580,000 shares $66.33 million +29.5%12.7%7.9 $41.98
6/15/20201,220,000 shares $55.05 million +3.4%9.8%6.3 $45.12
5/29/20201,180,000 shares $50.60 million -8.5%10.8%6.1 $42.88
5/15/20201,290,000 shares $66.32 million -9.2%11.8%6.7 $51.41
4/30/20201,420,000 shares $69.57 million -6.0%13.0%9.1 $48.99
4/15/20201,510,000 shares $90.60 million +3.4%13.8%9.5 $60.00
3/31/20201,460,000 shares $71.35 million -11.2%13.3%9.1 $48.87
3/13/20201,644,500 shares $72.72 million +11.1%20.8%11.2 $44.22
2/28/20201,480,000 shares $53.31 million -0.7%18.7%9.8 $36.02
2/14/20201,490,000 shares $80.45 million -12.9%13.7%9.5 $53.99
1/31/20201,710,000 shares $94.05 million +7.6%15.8%10.3 $55.00

Krystal Biotech (NASDAQ:KRYS) Short Interest FAQ

speech bubbles
speech bubbles











What is Krystal Biotech's current short interest?

Short interest is the volume of Krystal Biotech shares that have been sold short but have not yet been closed out or covered. As of January 29th, traders have sold 1,210,000 shares of KRYS short. 8.12% of Krystal Biotech's shares are currently sold short. View details.

What is a good short interest ratio for Krystal Biotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Krystal Biotech currently has a short interest ratio of 7.0.

What is a good short interest percentage for Krystal Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.12% of Krystal Biotech's floating shares are currently sold short.

Is Krystal Biotech's short interest increasing or decreasing?

Krystal Biotech saw a decrease in short interest during the month of January. As of January 29th, there was short interest totaling 1,210,000 shares, a decrease of 6.2% from the previous total of 1,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Krystal Biotech's float size?

Krystal Biotech currently has issued a total of 19,708,000 shares. Some of Krystal Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Krystal Biotech currently has a public float of 14,910,000 shares.

How does Krystal Biotech's short interest compare to its competitors?

8.12% of Krystal Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Krystal Biotech: Iovance Biotherapeutics, Inc. (0.00%), Kodiak Sciences Inc. (0.00%), Beam Therapeutics Inc. (17.12%), Allogene Therapeutics, Inc. (16.82%), China Biologic Products Holdings, Inc. (2.73%), SpringWorks Therapeutics, Inc. (9.26%), Relay Therapeutics, Inc. (12.09%), NantKwest, Inc. (18.76%), NanoString Technologies, Inc. (0.00%), and Editas Medicine, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Krystal Biotech stock?

Short selling KRYS is an investing strategy that aims to generate trading profit from Krystal Biotech as its price is falling. Krystal Biotech's stock is trading up $3.95 today. To short Krystal Biotech stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Krystal Biotech will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Krystal Biotech?

A short squeeze for Krystal Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRYS, which in turn drives the price of the stock up even further.

How often is Krystal Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRYS, twice per month. The most recent reporting period available is January, 29 2021.



This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.